Deficiency of Vitamin D, a Major Risk Factor for SARS-CoV-2 Severity

Area of Science:

• Medical Research
• Infectious Diseases
• Nutritional Science

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths globally.
• SARS-CoV-2 primarily affects the respiratory and cardiovascular systems, with outcomes ranging from asymptomatic to fatal.
• The study investigates the role of vitamin D in SARS-CoV-2 infection severity.

Purpose of the Study:

• To assess serum 25-hydroxyvitamin D (25-(OH)-D) levels in hospitalized and deceased SARS-CoV-2 patients.
• To analyze the correlation between vitamin D status and disease severity in COVID-19.

Main Methods:

• Study included 40 SARS-CoV-2 positive patients (20 hospitalized, 20 deceased).
• Blood and bronchial fluid samples were collected for laboratory analysis.
• Viral RNA was extracted and amplified using real-time PCR.

Main Results:

• Patients with severe SARS-CoV-2 disease exhibited decreased vitamin D levels.
• Lower vitamin D levels were associated with elevated D-dimers, C-reactive protein (CRP), and interleukin-6 (IL-6).
• These findings were observed in both living patients with severe disease and deceased individuals.

Conclusions:

• Vitamin D deficiency is a significant risk factor for severe COVID-19.
• Maintaining adequate vitamin D levels may be crucial for managing SARS-CoV-2 infection severity.
• Further research is warranted to explore vitamin D's therapeutic potential in COVID-19.